Biosimilar antibodies can be used to study the biological effects of a drug without the need for expensive pharmaceutical-grade therapeutic products. They can be used in a variety of research applications, including functional tests, flow cytometry, ELISA, immunohistochemistry, pharmacokinetic tests, and others. At present, the biological functions of monoclonal antibody drugs are mainly reflected in three aspects: inhibition of tumor survival key molecules, tumor immune intrinsic and adaptive activation, and antibody conjugated cytotoxic drugs. Monoclonal antibody targets are mainly focused on HERTNF, CD20, PD-1/L1, VEGF and CD3.
Biosimilar antibodies are developed with recombinant antibody expression technology using the same sequence as the therapeutic antibody and ensure specific binding to the same targeted molecule. The high quality biosimilar antibody products are usually produced in well-characterized cell lines with a long history of producing therapeutics.
Alpha Lifetech Inc. offers over 700 biosimilar antibody products against various targets. Our product list covers Adalimumab Biosimilar, Bevacizumab Biosimilar, Dupilumab Biosimilar, Eptinezumab Biosimilar, Rituximab Biosimilar, Teprotumumab Biosimilar, etc. Based on our professional antibody R&D team and rich experience in antibody expression production, we are confident in the quality of our biosimilar antibody products and strive to accelerate your research. Our biosimilar antibodies are available in a variety of sizes from ug to g level according to customers' demand. If there is no stock, it can be quickly expressed within 2-3 weeks.
Our biosimilar antibodies are of exceptional quality and consistency. Whether you order our product or speak to one of our technical service representatives, our staff is committed to providing professional support! For more information, please contact us and our technical support team will get back to you as soon as possible.